ABC dementia scale classifies Alzheimer’s disease patients into subgroups characterized by activities of daily living, behavioral and psychological symptoms of dementia, and cognitive function

Manuscript Number: 

19-0767R3

Author(s): 
Masahiro Akishita, Takashi Kikuchi, Takahiro Mori, Yu Nakamura, Yumi Umeda-Kameyama, Kenji Wada-Isoe

Disclosures

Masahiro Akishita

  • Lecture Fees:
    lecture fees from Astellas Pharma, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Eli Lilly Japan, Mitsubishi-Tanabe Pharma, Mochida Pharmaceutical, MSD, Pfizer Japan, Sumitomo Dainippon Pharma, and Takeda Pharmaceutical

Takashi Kikuchi

  • Nothing to Disclose

Takahiro Mori

  • Lecture Fees:
    In the past two years, I received two lecture fees from Daiichi Sankyo Co., Ltd. The amount of the lecture fees is 132,938 JPY.

Yu Nakamura

  • Consulting Fees:
    Biogen Japan Ltd., Ono Pharmaceutical Co., Ltd., Eisai Co., Ltd., Novartis Pharma K.K., MSD K.K.
    Lecture Fees:
    Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Eisai Co., Ltd., Novartis Pharma K.K., Eli Lilly Japan K.K., MSD K.K., Mochida Co., Ltd., Shionogi Co., Ltd., Phizer K.K.
    Grants
    • Agency: 
      Daiichi Sankyo Co., Ltd.
    • Agency: 
      Ono Pharmaceutical Co., Ltd.
    • Agency: 
      Takeda Pharmaceutical Co., Ltd.
    • Agency: 
      Eisai Co., Ltd.
    • Agency: 
      Novartis Pharma K.K.

Yumi Umeda-Kameyama

  • Nothing to Disclose

Kenji Wada-Isoe

  • Consulting Fees:
    I have served on medical advisory boards and received honoraria from Eisai and Otsuka Pharmaceutical
    Lecture Fees:
    I received honoraria for speaking engagements with DAIICHI SANKYO, Janssen Pharmaceuticals, Eisai, Takeda Pharma Corporation, ONO PHARMACEIUTICAL, FUJIFILM RI Pharma, Novartis Pharmaceuticals, Sumitomo Dainippon Pharma, Otsuka Pharmaceutical, Nihon Medi-Physics and